• RNA Clean and Concentrator Kit: High-Throughput RNA Purif...

  2026-01-30

  The RNA Clean and Concentrator Kit (SKU K1069) is a high-throughput RNA purification kit optimized for rapid cleanup of RNA from enzymatic reactions. It reliably removes unincorporated nucleotides and contaminants, delivering high-purity RNA suitable for molecular biology workflows. Its validated efficiency and broad compatibility make it a leading solution for in vitro transcription RNA cleanup.

• Ouabain as a Precision Probe: Unraveling Na+/K+-ATPase Si...

  2026-01-29

  Explore how ouabain, a selective Na+/K+-ATPase inhibitor, is reshaping cardiovascular and cellular research. This article reveals advanced insights into its mechanism, experimental strategies, and its role in decoding Na+ pump signaling pathways.

• 2-NBDG: Fluorescent Glucose Analog for Quantitative Gluco...

  2026-01-29

  2-NBDG is a validated fluorescent glucose analog enabling real-time, quantitative assessment of cellular glucose uptake in diverse biological models. This article details its mechanism, benchmarks for use, and critical parameters, establishing 2-NBDG as a gold-standard tool for glucose metabolism assays.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Precision Fluor...

  2026-01-28

  The FITC Goat Anti-Rabbit IgG (H+L) Antibody is a fluorescein-conjugated secondary antibody, optimized for ultra-sensitive detection in immunofluorescence and flow cytometry. Its affinity purification and robust signal amplification enable precise rabbit IgG detection, supporting biomarker discovery in translational research settings.

• Gastrin I (human): Precision Tools for Decoding Gastric A...

  2026-01-28

  Explore how Gastrin I (human) advances gastric acid secretion pathway research and elucidates CCK2 receptor signaling in sophisticated in vitro models. This article uncovers unique experimental strategies and mechanistic insights for gastrointestinal physiology studies.

• Applied Insights with BCL-XL Inhibitor A-1155463 in Cance...

  2026-01-27

  BCL-XL inhibitor A-1155463 (SKU B6163) empowers researchers to dissect apoptotic resistance in hematological malignancies and solid tumors with unprecedented selectivity and potency. This guide delivers actionable experimental workflows, data-driven troubleshooting tips, and strategic context for integrating this APExBIO compound into preclinical and translational studies.

• Veratridine: Precision Voltage-Gated Sodium Channel Opene...

  2026-01-27

  Veratridine, a steroidal alkaloid neurotoxin, is redefining sodium channel dynamics research and targeted cancer chemosensitivity modulation. Its unique mechanism as a voltage-gated sodium channel opener empowers next-generation experimental models and advanced screening assays. Discover how to optimize workflows, maximize reproducibility, and troubleshoot key challenges with this versatile APExBIO reagent.

• Applied Workflows with YC-1: sGC Activator & HIF-1α Inhib...

  2026-01-26

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol, a dual soluble guanylyl cyclase activator and HIF-1α inhibitor, empowers researchers to dissect hypoxia signaling and tumor angiogenesis with precision. This guide delivers actionable workflows, troubleshooting strategies, and comparative insights for maximizing reproducibility and impact in cancer and apoptosis research using APExBIO’s high-purity reagent.

• Gemcitabine: DNA Synthesis Inhibitor with Anti-Tumor Acti...

  2026-01-25

  Gemcitabine is a potent DNA synthesis inhibitor with robust anti-tumor activity, widely used in apoptosis and DNA damage response assays. Its mechanism disrupts DNA replication and activates checkpoint pathways, making it central to cancer research and overcoming chemoresistance.

• AZ505: Potent, Selective SMYD2 Inhibitor for Epigenetic a...

  2026-01-24

  AZ505, a potent and selective SMYD2 inhibitor, enables precise interrogation of the histone methylation pathway in epigenetic regulation research. Its substrate-competitive mechanism and high selectivity make it a gold-standard tool for cancer biology and fibrosis studies.

• nor-Binaltorphimine Dihydrochloride: Redefining κ-Opioid ...

  2026-01-24

  Explore how nor-Binaltorphimine dihydrochloride, a potent κ-opioid receptor antagonist, uniquely advances opioid receptor signaling research. This article delivers a systems-level analysis, integrating molecular pharmacology and translational neurobiology for cutting-edge pain and addiction studies.

• Verteporfin: Photosensitizer for Photodynamic Therapy & A...

  2026-01-23

  Verteporfin empowers researchers with dual-action capabilities as a precision photosensitizer for photodynamic therapy and a robust modulator of autophagy and apoptosis pathways. This article details optimized workflows, experimental troubleshooting, and innovative applications in ocular neovascularization, senescence, and cancer research that leverage Verteporfin’s unique light-dependent and independent mechanisms.

• Lamotrigine in Translational Neuropharmacology: Mechanist...

  2026-01-23

  This thought-leadership article examines Lamotrigine (SKU B2249) as a gold-standard sodium channel blocker and 5-HT inhibitor, guiding translational researchers through its mechanistic foundations, experimental utility, and strategic positioning in epilepsy and cardiac arrhythmia research. We contextualize Lamotrigine’s unique attributes within the evolving competitive and scientific landscape, integrating recent metabolism research and scenario-driven workflow considerations. The article elevates discourse beyond standard product listings by offering actionable insights for experimental design, regulatory translation, and innovation in blood-brain barrier and in vitro assay development.

• Optimizing Autophagy Assays: Scenario-Driven Best Practic...

  2026-01-22

  This article provides an evidence-based, scenario-driven guide for optimizing autophagy inhibition using MRT68921 (SKU B6174), a potent dual ULK1/2 kinase inhibitor. Drawing from real laboratory situations, it addresses protocol challenges, data interpretation, and product reliability, offering actionable insights for biomedical researchers. Leverage the rigor and reproducibility of MRT68921 for your preclinical autophagy research workflows.

• A-1331852: Selective BCL-XL Inhibitor for Precision Apopt...

  2026-01-22

  A-1331852 stands out as a next-generation, highly selective BCL-XL inhibitor, enabling researchers to dissect apoptosis mechanisms and drive preclinical cancer research with unmatched potency. Its robust performance in both monotherapy and combination regimens, especially in Molt-4 xenograft models and synergy with venetoclax, positions it as a critical tool for apoptosis assays and translational studies.

454 records 30/31 page Previous Next First page 上5页 2627282930 下5页 Last page